Status:
COMPLETED
Levetiracetam for Benign Rolandic Epilepsy
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
UCB Pharma
Conditions:
Epilepsy
Eligibility:
All Genders
6-12 years
Phase:
PHASE4
Brief Summary
This study is designed to test if the language problems commonly seen in children with benign rolandic epilepsy would improve by switching anticonvulsants to levetiracetam.
Detailed Description
This is a 6 month study in which children on another anticonvulsant would have EEG, language testing, and a clinic visit at baseline. They would then be rapidly transitioned off of their current antic...
Eligibility Criteria
Inclusion
- Ages 6-12
- Benign rolandic epilepsy
- Language difficulties as reported by parents or teachers
- On another anticonvulsant other than levetiracetam
Exclusion
- Prior use of levetiracetam
- On 2 or more anticonvulsants
- Language problems prior to epilepsy
- Another seizure disorder
- Status epilepticus within the past 6 months
- Significant psychiatric disease
- Progressive neurologic disease
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
End Date :
September 1 2006
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00181116
Start Date
March 1 2005
End Date
September 1 2006
Last Update
March 27 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21287